BioSyent Inc. (OTCMKTS:BIOYF – Get Free Report) was the recipient of a large decline in short interest during the month of April. As of April 15th, there was short interest totalling 500 shares, a decline of 83.3% from the March 31st total of 3,000 shares. Based on an average trading volume of 4,700 shares, the short-interest ratio is currently 0.1 days.
BioSyent Stock Performance
BioSyent stock remained flat at $6.28 on Friday. BioSyent has a 1-year low of $5.26 and a 1-year high of $6.97. The company has a fifty day simple moving average of $6.34 and a 200-day simple moving average of $6.28.
BioSyent Increases Dividend
The company also recently announced a dividend, which was paid on Friday, March 15th. Shareholders of record on Thursday, February 29th were given a dividend of $0.0332 per share. This is a positive change from BioSyent’s previous dividend of $0.03. The ex-dividend date of this dividend was Wednesday, February 28th. This represents a yield of 2.08%.
BioSyent Company Profile
BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.
Read More
- Five stocks we like better than BioSyent
- The How and Why of Investing in Gold Stocks
- 3 Stocks Leading the U.S. Agriculture Comeback
- Stock Market Sectors: What Are They and How Many Are There?
- How to Use Put Debit Spreads to Profit From Falling Stocks
- Following Congress Stock Trades
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.